Flexion Therapeutics, Inc.
|Number of Estimates|
Flexion Therapeutics, Inc. operates as a biopharmaceutical company, which engages in the development and commercialization of novel and local therapies. It specializes in the treatment of patients with musculoskeletal conditions including osteoarthritis. It offers products under the Zilretta brand. The company was founded by Michael D. Clayman and Neil Bodick in 2007 and is headquartered in Burlington, MA.
Market Cap: 676 Million
Primary Exchange: NASDAQ
Shares Outstanding: 38.2 Million
Float: 31.9 Million
Sector: Health Technology
Longest drawdown: 710 trading days
From: 2017-10-06 To: 2020-01-28
|Ex-Date||Payment Date||Record Date||Declared Date||Amount||Flag||Dividend Type||Qualified||Indicated|
|Ex-Date||Declared Date||Record Date||Payment Date||Ratio||To Factor||For Factor|